Kothari Fermentation opens special window for share transfer

1 min read     Updated on 05 Jun 2026, 12:37 PM
scanx
Reviewed by
Anirudha BScanX News Team
AI Summary

Kothari Fermentation & Biochem Limited has announced a special window for the transfer and dematerialisation of physical shares, effective following a SEBI circular dated January 30, 2026. The company published notices in the Financial Express and Jansatta on June 05, 2026, to inform shareholders. This step ensures compliance with regulations requiring listed entities to issue securities only in dematerialised form.

powered bylight_fuzz_icon
42188836

*this image is generated using AI for illustrative purposes only.

Kothari Fermentation & Biochem Limited has opened a special window to facilitate the transfer and dematerialisation of physical shares held by its shareholders. This initiative is pursuant to SEBI Circular No. HO/38/13/11(2)2026-MIRSD-POD/I/3750/2026 dated January 30, 2026, which mandates that listed entities issue securities only in dematerialised form.

The company disclosed this development through advertisements published on June 05, 2026, in the Financial Express (English) and Jansatta (Regional language). This communication serves as a second reminder to the exchange, following an initial disclosure dated February 7, 2026, and a first reminder dated April 6, 2026.

The special window provides an opportunity for shareholders holding physical share certificates to convert them into electronic form. This move aligns with the regulatory framework aimed at ensuring a fully dematerialised trading environment and reducing risks associated with physical securities.

The following table outlines the key details of the regulatory compliance:

Particulars Details
Regulatory Reference SEBI Circular No. HO/38/13/11(2)2026-MIRSD-POD/I/3750/2026
Circular Date January 30, 2026
Publication Date June 05, 2026
Newspapers Financial Express, Jansatta
Purpose Special Window for Transfer and Dematerialisation of Physical Shares

Shareholders are advised to utilize this facility to update their holdings. The submission to the BSE Limited was made by Shivani, Company Secretary & Compliance Officer, confirming the completion of the required newspaper publications.

Historical Stock Returns for Kothari Fermentation & Biochem

1 Day5 Days1 Month6 Months1 Year5 Years
+0.68%-0.84%+1.17%-8.02%-41.35%-47.36%

What penalties will Kothari Fermentation & Biochem face if physical shares remain dematerialised after the special window closes?

How will this mandatory dematerialisation impact the liquidity and trading volume of the company's stock?

Is the company prepared for a potential reduction in its shareholder base due to the compliance costs associated with dematerialisation?

Kothari Fermentation & Biochem
View Company Insights
View All News
like16
dislike

Kothari Fermentation reports net loss in FY26

2 min read     Updated on 29 May 2026, 11:40 PM
scanx
Reviewed by
Jubin VScanX News Team
AI Summary

Kothari Fermentation & Biochem reported a net loss of ₹298.93 lakh for FY26 against a profit of ₹80.99 lakh in FY25, with revenue dipping to ₹11,213.19 lakh. The Board approved the audited results and appointed M/s Arun K. Garg & Associates as internal auditors for the upcoming fiscal year.

powered bylight_fuzz_icon
41623795

*this image is generated using AI for illustrative purposes only.

Kothari Fermentation & Biochem reported a net loss of ₹298.93 lakh for the financial year ended March 31, 2026, reversing the net profit of ₹80.99 lakh recorded in the previous year. The company's revenue from operations declined to ₹11,213.19 lakh for FY26, down from ₹11,423.10 lakh in the corresponding period of the previous year. Total income for the year stood at ₹11,286.87 lakh.

The Board of Directors approved the audited financial statements and results for the standalone financial year ended March 31, 2026, at a meeting held on May 29, 2026. The statutory auditors, M/s Kothari Kuldeep & Co., issued an audit report with an unmodified opinion on the financial results. The company also appointed M/s Arun K. Garg & Associates as internal auditors for FY 2026-27.

For the quarter ended March 31, 2026, the company reported a net profit of ₹127.26 lakh, a recovery from the net loss of ₹37.84 lakh in the quarter ended December 31, 2025. Revenue from operations for the fourth quarter was ₹3,246.80 lakh, slightly higher than the ₹3,217.87 lakh reported in the same quarter of the previous year. Total expenses for the full year increased to ₹11,633.10 lakh from ₹11,238.43 lakh in FY25.

Financial Performance

The company's earnings per share (EPS) for the full year was negative at ₹(1.99), compared to a positive EPS of ₹0.54 in the previous year. Basic and diluted EPS for the quarter ended March 31, 2026, stood at ₹0.85. The total comprehensive income for the year was a loss of ₹262.22 lakh, compared to an income of ₹66.46 lakh in the prior year.

Particulars Year ended 31.03.2026 (₹ in Lakhs) Year ended 31.03.2025 (₹ in Lakhs)
Revenue from operations 11,213.19 11,423.10
Total Income 11,286.87 11,432.29
Total Expenses 11,633.10 11,238.43
Net Profit/(Loss) for the period (298.93) 80.99
Earnings Per Share (Basic) (1.99) 0.54

Balance Sheet Highlights

The company's total assets stood at ₹12,654.72 lakh as of March 31, 2026, a marginal decrease from ₹12,791.66 lakh in the previous year. Non-current liabilities rose significantly to ₹5,468.54 lakh from ₹3,881.07 lakh, driven by an increase in borrowings to ₹4,279.66 lakh from ₹2,673.40 lakh. Current liabilities decreased to ₹1,791.27 lakh from ₹3,253.45 lakh, primarily due to a reduction in short-term borrowings.

Particulars as at 31.03.2026 (₹ in Lakhs) as at 31.03.2025 (₹ in Lakhs)
Total Assets 12,654.72 12,791.66
Total Equity 5,394.91 5,657.14
Total Liabilities 7,259.81 7,134.52
Borrowings (Non-current) 4,279.66 2,673.40

Historical Stock Returns for Kothari Fermentation & Biochem

1 Day5 Days1 Month6 Months1 Year5 Years
+0.68%-0.84%+1.17%-8.02%-41.35%-47.36%

What specific factors drove the significant increase in non-current borrowings during the fiscal year?

Can the recovery in net profit during the March 2026 quarter be sustained into the upcoming fiscal year?

How does the company plan to manage the rising interest costs associated with the increased debt load?

Kothari Fermentation & Biochem
View Company Insights
View All News
like15
dislike

More News on Kothari Fermentation & Biochem

1 Year Returns:-41.35%